Learning Objectives
By the end of this session, the learner will be able to identify key SNRIs, describe their dual mechanism of action, recognize their unique clinical applications in pain management, and identify the specific side-effect profile (particularly blood pressure changes).
1. Mechanism and Drugs
SNRIs provide “dual coverage” by increasing the synaptic concentration of both serotonin and norepinephrine. Unlike SSRIs, which are selective for serotonin, SNRIs modulate two major neurotransmitter systems.
| Mechanism | Primary SNRI Drugs |
|---|---|
| Inhibition of both 5-HT (Serotonin) and NE (Norepinephrine) reuptake. | Venlafaxine, Desvenlafaxine, Duloxetine. |
2. Clinical Indications
The addition of norepinephrine modulation makes SNRIs particularly useful for conditions involving descending pain inhibitory pathways in the spinal cord.
| Condition | Role of SNRIs | High-Yield Note |
|---|---|---|
| Major Depression | First or second-line therapy. | Often used when SSRIs are insufficient. |
| Anxiety Disorders | Chronic prevention of GAD and Social Anxiety. | Similar efficacy to SSRIs for anxiety. |
| Chronic Pain | Neuropathic pain and Fibromyalgia. | Duloxetine is the drug of choice for diabetic neuropathy. |
3. Side Effects and Toxicity
Because they increase norepinephrine, SNRIs carry risks related to sympathetic nervous system activation.
| Side Effect | Clinical Implication |
|---|---|
| Increased Blood Pressure | Most common with high-dose Venlafaxine. Monitor BP regularly. |
| Sexual Dysfunction | Decreased libido and anorgasmia (similar to SSRIs). |
| Somnolence | Daytime drowsiness. |
| Bleeding Risk | Increased risk when used with NSAIDs or anticoagulants. |
Critical Concept: Serotonin Syndrome
Avoid combining SNRIs with:
- MAOIs (must allow a “washout” period).
- TCAs or other SSRIs.
- Linezolid (an antibiotic with MAOI activity).
- Tramadol or Meperidine (opioids with serotonergic effects).
Clinical Pearls:
- Diabetic Neuropathy: If a patient presents with “burning” foot pain and depression, Duloxetine is the most appropriate single-agent therapy.
- Hypertension: If a patient’s BP is already uncontrolled, SSRIs are generally preferred over SNRIs to avoid further elevation.
- St. John’s Wort: This herbal supplement is a common “trap” in exam questions; it can trigger serotonin syndrome when mixed with SNRIs.